Evolus Inc (LTS:0K16)
$ 16.611 -0.1026 (-0.62%) Market Cap: 1.04 Bil Enterprise Value: 1.07 Bil PE Ratio: 0 PB Ratio: 53.62 GF Score: 48/100

Q3 2023 Evolus Inc Earnings Call Transcript

Nov 07, 2023 / 09:30PM GMT
Release Date Price: $7.7
Operator

Good afternoon, and welcome to the Evolus Third Quarter 2023 Earnings Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.

I would now like to turn the conference over to your host, Mr. Ned Mitchell from Investor Relations. Ned?

Ned Mitchell

Thank you, operator, and welcome to everyone joining us on today's call. With me today are David Moatazedi, President and Chief Executive Officer; Rui Avelar, Chief Medical Officer and Head of R&D; and Sandra Beaver, Chief Financial Officer.

Our prepared remarks today will include forward-looking statements within the meaning of United States securities laws, and management may make additional forward-looking statements in response to your questions. Forward-looking statements are based on management's current assumptions and expectations of future events and trends, which may affect the company's business, strategy, operations or financial performance.

A detailed discussion of the risks and uncertainties that the company faces is contained in its annual report

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot